Lawsuit filed against RFK Jr over vaccine policy changes; oral on-demand treatment approved for HAE; OTC cuffless blood pressure monitor gets greenlit; ...

The REMS program for the ERA drug class was established due to the risk of embryofetal toxicity seen from animal studies.

Both 6-month trials were randomized, controlled studies that evaluated PER-001 delivered in a slow-release, dissolvable ...

In this Healio Video Perspective from Clinical Trials at the Summit, Arshad M. Khanani, MD, MA, FASRS, highlights first-time ...

The CDE of China's NMPA has granted BioCity's endothelin receptor type A (ETA) antagonist, SC0062, a second BTD.

With its demonstrated clinical benefits and superior selectivity profile, SC0062 is positioned to potentially become a best-in-class renal therapeutic. BioCity remains committed to advancing this ...

Erythritol may impair cellular functions essential to maintaining brain blood vessel health, according to researchers at the University of Colorado Boulder. Findings suggest that erythritol increases ...

通过阻断 Endothelin - 2 与受体的结合，抑制其引发的血管收缩和细胞增殖等病理过程 。在心血管疾病研究和治疗中，这些拮抗剂多肽与 Big Endothelin - 2 (1 - 38), Huma… ...

Patients with systemic sclerosis (SSc) have elevated endothelin-1 concentrations compared to healthy controls, according to a meta-analysis.

The researchers examined the effect of three antioxidants—luteolin, hesperetin, and diosmetin—on mice specially bred to gray ...

Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "Endothelin Receptor Antagonist - Pipeline Insight, 2025" clinical trials has been added to ResearchAndMarkets.com's offering. This report provides ...